Daniela Bärtschi

409 total citations
6 papers, 292 citations indexed

About

Daniela Bärtschi is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Daniela Bärtschi has authored 6 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Hematology. Recurrent topics in Daniela Bärtschi's work include Colorectal Cancer Treatments and Studies (2 papers), Colorectal Cancer Surgical Treatments (2 papers) and Cancer Treatment and Pharmacology (2 papers). Daniela Bärtschi is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), Colorectal Cancer Surgical Treatments (2 papers) and Cancer Treatment and Pharmacology (2 papers). Daniela Bärtschi collaborates with scholars based in Switzerland, Germany and Chile. Daniela Bärtschi's co-authors include Richard Cathomas, Christian Rothermundt, Arnoud J. Templeton, Ralph Schiess, Silke Gillessen, Jan H. Rüschoff, Stefanie Hayoz, Räto T. Strebel, Markus Borner and Michaël Pollak and has published in prestigious journals such as Cancer, European Urology and European Journal of Cancer.

In The Last Decade

Daniela Bärtschi

6 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Bärtschi Switzerland 5 156 141 132 81 29 6 292
Stephen Brincat United States 7 195 1.3× 233 1.7× 238 1.8× 68 0.8× 25 0.9× 9 478
C. Massard France 11 141 0.9× 130 0.9× 87 0.7× 55 0.7× 29 1.0× 40 325
Xin‐Gan Qin China 11 139 0.9× 114 0.8× 96 0.7× 69 0.9× 84 2.9× 25 316
Maddalena Donini Italy 8 69 0.4× 112 0.8× 64 0.5× 49 0.6× 45 1.6× 29 191
Shrijal S. Shah United States 7 235 1.5× 113 0.8× 48 0.4× 80 1.0× 12 0.4× 7 395
Hiroshi Nishimiya Japan 11 166 1.1× 57 0.4× 120 0.9× 81 1.0× 53 1.8× 23 313
Andrew Krivoshik United States 7 67 0.4× 225 1.6× 162 1.2× 66 0.8× 50 1.7× 11 321
Laura Belvederesi Italy 12 125 0.8× 116 0.8× 210 1.6× 174 2.1× 55 1.9× 29 467
Hidenori Fujita Japan 8 171 1.1× 54 0.4× 105 0.8× 34 0.4× 65 2.2× 18 283
Bharani Dharan United States 6 152 1.0× 120 0.9× 144 1.1× 59 0.7× 17 0.6× 10 324

Countries citing papers authored by Daniela Bärtschi

Since Specialization
Citations

This map shows the geographic impact of Daniela Bärtschi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Bärtschi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Bärtschi more than expected).

Fields of papers citing papers by Daniela Bärtschi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Bärtschi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Bärtschi. The network helps show where Daniela Bärtschi may publish in the future.

Co-authorship network of co-authors of Daniela Bärtschi

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Bärtschi. A scholar is included among the top collaborators of Daniela Bärtschi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Bärtschi. Daniela Bärtschi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Bovet, Cédric, Regula Theurillat, Laurent A. Décosterd, et al.. (2022). Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP). British Journal of Clinical Pharmacology. 88(12). 5336–5347. 1 indexed citations
2.
Montemurro, Michael, Angela Cioffi, Julien Dômont, et al.. (2018). Long‐term outcome of dasatinib first‐line treatment in gastrointestinal stromal tumor: A multicenter, 2‐stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07). Cancer. 124(7). 1449–1454. 34 indexed citations
3.
Moos, Roger von, Dieter Koeberle, Stefanie Hayoz, et al.. (2017). Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS -mutated rectal cancer: A phase I/II trial (SAKK 41/08). European Journal of Cancer. 89. 82–89. 20 indexed citations
5.
Rothermundt, Christian, Stefanie Hayoz, Arnoud J. Templeton, et al.. (2014). Metformin in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Phase 2 Trial (SAKK 08/09). European Urology. 66(3). 468–474. 92 indexed citations
6.
Templeton, Arnoud J., Valérie Dutoit, Richard Cathomas, et al.. (2013). Phase 2 Trial of Single-agent Everolimus in Chemotherapy-naive Patients with Castration-resistant Prostate Cancer (SAKK 08/08). European Urology. 64(1). 150–158. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026